Arvinas (ARVN) Non-Current Debt (2017 - 2026)
Arvinas (ARVN) reported Non-Current Debt of $300,000 for Q2 2026, down 40.0% from $500,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) Non-Current Debt (2017 - 2026) Analysis & Trends
At the end of FY2025, Arvinas posted Non-Current Debt of $400,000, down 33.3% from FY2024.
- Non-Current Debt has declined for three consecutive years, with a five-year compound annual growth rate of -27.5% (FY2020 to FY2025).
- By year, Non-Current Debt came in at $600,000 in FY2024 (-25.0%), $800,000 in FY2023 (-20.0%), $1 million in FY2022 (unchanged) and $1 million in FY2021 (-50.0%).
- Five-year quarterly Non-Current Debt spans a low of $300,000 in Q1 2026 and a high of $1 million in Q4 2022.
- Year over year, Non-Current Debt has now declined in each of the last 14 quarters, with an average decline of 31.7% over the last eight quarters.
- The year-over-year decline in Non-Current Debt has ranged between 0.0% (Q4 2022) and 50.0% (Q3 2021) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $300,000 (Q1 2026), $400,000 (Q4 2025) and $400,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Arvinas | 490.40 Mn | -2.17 Bn | - | 300,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 700,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 900,000.00 |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 1.00 Mn |
API Access
Arvinas Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();